ocal anaesthesia prior to intramuscular Magnesium Sulphate injection to reduce pain: A randomised crossover pilot study
Phase 1
- Conditions
- Pain in patient with preeclampsia and eclampsia receiving intramuscular magnesium sulphate.
- Registration Number
- PACTR202201521544765
- Lead Sponsor
- niversity of Botswana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 34
Inclusion Criteria
Patient with preeclampsia or eclampsia receiving magnesium sulphate
Client willing and consenting to take part in the study
Conscious, able to give consent and give answers to questions about pain and preference
Exclusion Criteria
Age less than 18 years (consenting age )
critically ill patient (very sick, unstable or unconscious patient, GCS <13 or haemo-dynamically unstable patient)
Allergic to magnesium sulphate or lignocaine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method